Megakaryocytes are large, specialized cells found in the bone marrow, responsible for the production of platelets, essential components involved in blood clotting and coagulation. These unique cells undergo a process called thrombopoiesis, where they give rise to platelets through fragmentation of their cytoplasm. Megakaryocytes are characterized by their large size, multilobulated nuclei, and abundant cytoplasmic granules. The regulation of megakaryocyte development and platelet production is tightly controlled by various growth factors, including thrombopoietin. As megakaryocytes mature, they extend long cytoplasmic projections, known as proplatelets, into the bone marrow sinusoids, facilitating the release of platelets into the bloodstream. The intricate balance between megakaryocyte proliferation and platelet release is crucial for maintaining proper hemostasis and preventing excessive bleeding or clotting disorders. Dysregulation of megakaryocyte function is implicated in various hematological conditions, such as thrombocytopenia or myeloproliferative disorders. Understanding the biology of megakaryocytes is vital for deciphering the mechanisms governing platelet production and thrombopoiesis. Ongoing research in hematology aims to uncover the molecular pathways involved in megakaryocyte maturation and platelet release, paving the way for potential therapeutic interventions in bleeding and clotting disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States